hormone

Veru touts novel breast cancer treatment strategy

Veru aims to launch a phase 3 study of its androgen receptor agonist enobosarm in heavily pretreated ER-positive/HER2-negative breast cancer.

Angus Liu Jan 21, 2021 7:31am

BridgeBio's en route to proving out its 'Moneyball' model: CEO

Sep 29, 2020 7:00am

Spruce scores phase 2a win for rare disease drug, preps for 2020

Sep 19, 2019 8:00am

A new approach to resistant prostate cancer

Aug 29, 2019 9:00am

Could the 'hunger hormone' boost memory?

Jul 10, 2019 10:20am

New insight into melatonin could lead to better sleep drugs

Apr 25, 2019 12:58pm